{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T10:27:26Z","timestamp":1794306446235,"version":"4.9.0"},"reference-count":199,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.parkreldis.2021.05.026","type":"journal-article","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T11:17:12Z","timestamp":1622287032000},"page":"116-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Movement disorders in systemic autoimmune diseases: Clinical spectrum, ancillary investigations, pathophysiological considerations"],"prefix":"10.1016","volume":"88","author":[{"given":"Elisa","family":"Menozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eoin","family":"Mulroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladan","family":"Akbarian-Tefaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailash P.","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Balint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.parkreldis.2021.05.026_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/brain\/awx189","article-title":"Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology","volume":"141","author":"Balint","year":"2018","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.parkreldis.2021.05.026_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00005792-199705000-00006","article-title":"Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature","volume":"76","author":"Cervera","year":"1997","journal-title":"Medicine (Baltim.)"},{"issue":"11","key":"10.1016\/j.parkreldis.2021.05.026_bib3","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.3899\/jrheum.080268","article-title":"Antiphospholipid antibody-associated chorea","volume":"35","author":"Orzechowski","year":"2008","journal-title":"J. Rheumatol."},{"issue":"13","key":"10.1016\/j.parkreldis.2021.05.026_bib4","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1002\/mds.23863","article-title":"Long-term outcome of 32 patients with chorea and systemic lupus erythematosus or antiphospholipid antibodies","volume":"26","author":"Reiner","year":"2011","journal-title":"Mov. Disord."},{"issue":"1\u20132","key":"10.1016\/j.parkreldis.2021.05.026_bib5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0022-510X(94)90204-6","article-title":"A neuropathological study of a case of lupus erythematosus with chorea","volume":"123","author":"Kuroe","year":"1994","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.05.026_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/096120339500400416","article-title":"Hemichorea in systemic lupus erythematosus: significance of MRI findings","volume":"4","author":"al Jishi","year":"1995","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.parkreldis.2021.05.026_bib7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00467-003-1388-6","article-title":"Hemichorea with antiphospholipid antibodies in a patient with lupus nephritis","volume":"19","author":"Watanabe","year":"2004","journal-title":"Pediatr. Nephrol."},{"issue":"12","key":"10.1016\/j.parkreldis.2021.05.026_bib8","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1007\/s10067-007-0627-9","article-title":"Efficacy of intravenous immunoglobulin treatment in lupus erythematosus chorea","volume":"26","author":"Lazurova","year":"2007","journal-title":"Clin. Rheumatol."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.05.026_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/RHU.0b013e31820e7c8d","article-title":"Chorea in systemic lupus erythematosus","volume":"17","author":"Baizabal-Carvallo","year":"2011","journal-title":"J. Clin. Rheumatol."},{"key":"10.1016\/j.parkreldis.2021.05.026_bib10","first-page":"317082","article-title":"Chorea as the first sign in a patient with elderly-onset systemic lupus erythematosus","volume":"2012","author":"Ariizumi","year":"2012","journal-title":"Case Rep Neurol Med"},{"key":"10.1016\/j.parkreldis.2021.05.026_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4137\/CCRep.S9143","article-title":"Chorea as a first manifestation in young patients with systemic lupus erythematosus who was initially diagnosed with rheumatic Fever","volume":"5","author":"Albishri","year":"2012","journal-title":"Clin. Med. Insights Case Rep."},{"key":"10.1016\/j.parkreldis.2021.05.026_bib12","first-page":"907402","article-title":"Chorea as the first and only manifestation of systemic lupus erythematosus","volume":"2012","author":"Poil","year":"2012","journal-title":"Case Rep Rheumatol"},{"issue":"1","key":"10.1016\/j.parkreldis.2021.05.026_bib13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1546-0096-11-36","article-title":"Chorea, a little-known manifestation in systemic lupus erythematosus: short literature review and four case reports","volume":"11","author":"Torreggiani","year":"2013","journal-title":"Pediatr Rheumatol Online J"},{"issue":"9","key":"10.1016\/j.parkreldis.2021.05.026_bib14","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.braindev.2015.01.008","article-title":"Mixed movements disorders as an initial feature of pediatric lupus","volume":"37","author":"Mrabet","year":"2015","journal-title":"Brain Dev."},{"issue":"10","key":"10.1016\/j.parkreldis.2021.05.026_bib15","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1097\/PEC.0000000000000829","article-title":"Unusual presentations of childhood systemic lupus erythematosus to the emergency department","volume":"33","author":"G\u00fcltekingil Keser","year":"2017","journal-title":"Pediatr. Emerg. Care"},{"issue":"1","key":"10.1016\/j.parkreldis.2021.05.026_bib16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/RLU.0000000000001450","article-title":"Glucose hypermetabolism in contralateral basal ganglia demonstrated by serial FDG PET\/CT scans in a patient with SLE chorea","volume":"42","author":"Niu","year":"2017","journal-title":"Clin. Nucl. Med."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.05.026_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/08830185.2018.1452920","article-title":"Chorea revealing systemic lupus erythematosus in a 13-year old boy: a case report and short review of the literature","volume":"37","author":"Athanasopoulos","year":"2018","journal-title":"Int. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.parkreldis.2021.05.026_bib18","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/mds.21657","article-title":"Clinical and positron emission tomography findings of chorea associated with primary antiphospholipid antibody syndrome","volume":"22","author":"Wu","year":"2007","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.05.026_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/mds.870130127","article-title":"Reversible chorea in primary antiphospholipid syndrome","volume":"13","author":"Sund\u00e9n-Cullberg","year":"1998","journal-title":"Mov. Disord."},{"issue":"1\u20132","key":"10.1016\/j.parkreldis.2021.05.026_bib20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jns.2009.03.011","article-title":"Complex movement disorders in primary antiphospholipid syndrome: a case report","volume":"281","author":"Carecchio","year":"2009","journal-title":"J. Neurol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.parkreldis.2021.05.026_bib21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jns.2009.05.009","article-title":"Narrowing the window for 'senile chorea': a case with primary antiphospholipid syndrome","volume":"284","author":"Gelosa","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2021.05.026_bib22","first-page":"471543","article-title":"Antiphospholipid antibody syndrome presenting with hemichorea","volume":"2012","author":"Ayalew","year":"2012","journal-title":"Case Rep Rheumatol"},{"key":"10.1016\/j.parkreldis.2021.05.026_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2018.04.011","article-title":"Beneficial effect of intravenous immunoglobulin treatment in a patient with antiphospholipid syndrome associated chorea","volume":"390","author":"Dombernowsky","year":"2018","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.05.026_bib24","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/practneurol-2017-001824","article-title":"Oromandibular chorea in antiphospholipid syndrome","volume":"18","author":"Zhang","year":"2018","journal-title":"Practical Neurol."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.05.026_bib25","first-page":"66","article-title":"Chorea and retinal vessel occlusion in a patient with systemic lupus erythematosus","volume":"12","author":"Ostovan","year":"2013","journal-title":"Iran J Neurol"},{"issue":"2","key":"10.1016\/j.parkreldis.2021.05.026_bib26","first-page":"117","article-title":"Neurological presentations of the antiphospholipid syndrome: three illustrative cases","volume":"114","author":"De Maeseneire","year":"2014","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.parkreldis.2021.05.026_bib27","first-page":"2548142","article-title":"Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus","author":"Khajezadeh","year":"2018","journal-title":"Neurol Res Int"},{"issue":"2","key":"10.1016\/j.parkreldis.2021.05.026_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055843","article-title":"Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients","volume":"8","author":"Kampylafka","year":"2013","journal-title":"PloS One"},{"issue":"10","key":"10.1016\/j.parkreldis.2021.05.026_bib29","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1177\/0961203309106832","article-title":"The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe","volume":"18","author":"Cervera","year":"2009","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/j.parkreldis.2021.05.026_bib30","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1007\/s00296-011-2120-7","article-title":"Chorea in primary antiphospholipid syndrome is associated with rheumatic fever","volume":"32","author":"Appenzeller","year":"2012","journal-title":"Rheumatol. Int."},{"issue":"9","key":"10.1016\/j.parkreldis.2021.05.026_bib31","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nrrheum.2017.124","article-title":"Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances","volume":"13","author":"Sciascia","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"issue":"5","key":"10.1016\/j.parkreldis.2021.05.026_bib32","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.autrev.2015.01.002","article-title":"The relevance of \"non-criteria\" clinical manifestations of antiphospholipid syndrome: 14th international congress on antiphospholipid antibodies technical task force report on antiphospholipid syndrome clinical features","volume":"14","author":"Abreu","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.parkreldis.2021.05.026_bib33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/B978-0-444-52014-2.00014-8","article-title":"Sydenham's chorea","volume":"100","author":"Cardoso","year":"2011","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.parkreldis.2021.05.026_bib34","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.spen.2018.01.002","article-title":"Inherited and acquired choreas","volume":"25","author":"de Gusmao","year":"2018","journal-title":"Semin. Pediatr. Neurol."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.05.026_bib35","doi-asserted-by":"crossref","first-page":"200","DOI":"10.5152\/npa.2015.7316","article-title":"Neuro-Behcet's disease with chorea","volume":"52","author":"Gur Ozmen","year":"2015","journal-title":"Noro Psikiyatr Ars"},{"issue":"2","key":"10.1016\/j.parkreldis.2021.05.026_bib36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1468-1331.2006.01613.x","article-title":"Neuro-Behcet's disease in Caucasians: a study of 22 patients","volume":"14","author":"Joseph","year":"2007","journal-title":"Eur. J. Neurol."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.05.026_bib37","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s10067-004-0897-4","article-title":"Neuro-Behcet's disease with chorea after remission of intestinal Behcet's disease","volume":"23","author":"Kuriwaka","year":"2004","journal-title":"Clin. Rheumatol."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.05.026_bib38","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.autrev.2015.11.011","article-title":"Behcet disease presenting with movement disorders and antibasal ganglia antibodies","volume":"15","author":"Rizzo","year":"2016","journal-title":"Autoimmun. Rev."},{"issue":"6","key":"10.1016\/j.parkreldis.2021.05.026_bib39","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.pediatrneurol.2015.02.021","article-title":"Chorea as the initial manifestation of Sjogren syndrome","volume":"52","author":"Delorme","year":"2015","journal-title":"Pediatr. Neurol."},{"issue":"5","key":"10.1016\/j.parkreldis.2021.05.026_bib40","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.parkreldis.2008.06.007","article-title":"Bilateral basal ganglia lesions of primary Sjogren syndrome presenting with generalized chorea","volume":"15","author":"Min","year":"2009","journal-title":"Park. Relat. Disord."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.05.026_bib41","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.parkreldis.2004.10.006","article-title":"Primary Sjogren's syndrome presenting as a generalized chorea","volume":"11","author":"Venegas Fanchke","year":"2005","journal-title":"Park. Relat. Disord."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.05.026_bib42","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/practneurol-2019-002396","article-title":"Coeliac disease presenting with chorea","volume":"20","author":"Lefter","year":"2020","journal-title":"Practical Neurol."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.05.026_bib43","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/mds.10691","article-title":"Choreic syndrome and coeliac disease: a hitherto unrecognised association","volume":"19","author":"Pereira","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.05.026_bib44","series-title":"Further Evidence for Celiac Disease-Associated Chorea","first-page":"1","author":"Walker","year":"2011"},{"key":"10.1016\/j.parkreldis.2021.05.026_bib45","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clineuro.2015.07.009","article-title":"Gluten chorea","volume":"138","author":"Andrade","year":"2015","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.05.026_bib46","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/014107680209500307","article-title":"Refractory coeliac disease, small-bowel lymphoma and chorea","volume":"95","author":"Kitiyakara","year":"2002","journal-title":"J. R. Soc. Med."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.05.026_bib47","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/07853890.2017.1412088","article-title":"Autoimmune rheumatic diseases and the risk of Parkinson disease: a nationwide population-based cohort study in Taiwan","volume":"50","author":"Chang","year":"2018","journal-title":"Ann. Med."},{"key":"10.1016\/j.parkreldis.2021.05.026_bib48","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-020-05053-z","article-title":"Higher risk of Parkinson disease in patients with primary Sjogren's syndrome","author":"Hsu","year":"2020","journal-title":"Clin. Rheumatol."},{"issue":"14","key":"10.1016\/j.parkreldis.2021.05.026_bib49","article-title":"Risk of Parkinson disease in Sjogren syndrome administered ineffective immunosuppressant therapies: a nationwide population-based study","volume":"98","author":"Ju","year":"2019","journal-title":"Medicine (Baltim.)"},{"issue":"7","key":"10.1016\/j.parkreldis.2021.05.026_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175836","article-title":"Impact of Sjogren's syndrome on Parkinson's disease: a nationwide case-control study","volume":"12","author":"Wu","year":"2017","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.parkreldis.2021.05.026_bib51","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/mds.870120124","article-title":"Primary Sjogren's syndrome presenting as progressive parkinsonian syndrome","volume":"12","author":"Creange","year":"1997","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.parkreldis.2021.05.026_bib52","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10067-006-0398-8","article-title":"Anti-beta2-glycoprotein I in Sjogren's syndrome is associated with parkinsonism","volume":"26","author":"Hassin-Baer","year":"2007","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.parkreldis.2021.05.026_bib53","doi-asserted-by":"crossref","first-page":"432910","DOI":"10.1155\/2015\/432910","article-title":"Parkinsonism and sjogren's syndrome: a fortuitous association or a shared immunopathogenesis?","volume":"2015","author":"Kchaou","year":"2015","journal-title":"Case Rep Med"},{"issue":"2","key":"10.1016\/j.parkreldis.2021.05.026_bib54","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00296-014-3097-9","article-title":"Frequent involvement of central nervous system in primary Sjogren syndrome","volume":"35","author":"Moreira","year":"2015","journal-title":"Rheumatol. Int."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.05.026_bib55","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0303-8467(94)90124-4","article-title":"Corticosteroid-responsive parkinsonism associated with primary Sjogren's syndrome","volume":"96","author":"Nishimura","year":"1994","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.parkreldis.2021.05.026_bib56","first-page":"5696512","article-title":"A case report of nonvasculitic autoimmune inflammatory meningoencephalitis with sensory ganglionopathy: a rare presentation of sjogren syndrome","volume":"2017","author":"Peres","year":"2017","journal-title":"Case Rep Neurol Med"},{"issue":"2","key":"10.1016\/j.parkreldis.2021.05.026_bib57","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0303-8467(93)90009-6","article-title":"Hemiparkinsonism in a patient with primary Sjogren's syndrome. A case report and a review of the literature","volume":"95","author":"Visser","year":"1993","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.05.026_bib58","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/1531-8257(199903)14:2<262::AID-MDS1011>3.0.CO;2-6","article-title":"Parkinsonism associated with Sjogren's syndrome: three cases and a review of the literature","volume":"14","author":"Walker","year":"1999","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.05.026_bib59","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.autrev.2010.09.001","article-title":"The meaning of anti-Ro and anti-La antibodies in primary Sjogren's syndrome","volume":"10","author":"Hernandez-Molina","year":"2011","journal-title":"Autoimmun. Rev."},{"issue":"46","key":"10.1016\/j.parkreldis.2021.05.026_bib60","article-title":"Inverse association of Parkinson disease with systemic lupus erythematosus: a nationwide population-based study","volume":"94","author":"Liu","year":"2015","journal-title":"Medicine (Baltim.)"},{"issue":"3","key":"10.1016\/j.parkreldis.2021.05.026_bib61","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/mds.10029","article-title":"Reversible parkinsonian syndrome in systemic and brain vasculitis","volume":"17","author":"Fabiani","year":"2002","journal-title":"Mov. Disord."},{"issue":"1\u20132","key":"10.1016\/j.parkreldis.2021.05.026_bib62","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jns.2015.09.373","article-title":"Bilateral striatopallidodentate calcinosis associated with systemic lupus erythematosus: case report and review of literature","volume":"358","author":"Chang","year":"2015","journal-title":"J. Neurol. Sci."},{"issue":"6","key":"10.1016\/j.parkreldis.2021.05.026_bib63","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1469-8749.2011.03922.x","article-title":"Antibody binding to neuronal surface in movement disorders associated with lupus and antiphospholipid antibodies","volume":"53","author":"Dale","year":"2011","journal-title":"Dev. Med. Child Neurol."},{"issue":"8","key":"10.1016\/j.parkreldis.2021.05.026_bib64","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/0961203307081421","article-title":"Unusual neurologic manifestations (I): parkinsonism in juvenile SLE","volume":"16","author":"Khubchandani","year":"2007","journal-title":"Lupus"},{"issue":"5 Pt 1","key":"10.1016\/j.parkreldis.2021.05.026_bib65","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0091-6749(95)70268-7","article-title":"Antidopaminergic antibodies in a patient with a complex autoimmune disorder and rapidly progressing Parkinson's disease","volume":"96","author":"Kunas","year":"1995","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.parkreldis.2021.05.026_bib66","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1191\/096120300678828578","article-title":"Parkinsonism as unusual neurological complication in childhood systemic lupus erythematosus","volume":"9","author":"Kwong","year":"2000","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.parkreldis.2021.05.026_bib67","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1212\/01.WNL.0000130255.16674.9B","article-title":"Basal ganglia hyperperfusion in a patient with systemic lupus erythematosus-related parkinsonism","volume":"63","author":"Lee","year":"2004","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.parkreldis.2021.05.026_bib68","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/096120339300200314","article-title":"Parkinson-like symptoms as a manifestation of systemic lupus erythematosus","volume":"2","author":"Miyoshi","year":"1993","journal-title":"Lupus"},{"issue":"7","key":"10.1016\/j.parkreldis.2021.05.026_bib69","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/096120339700600710","article-title":"Systemic lupus erythematosus associated with transverse myelitis and parkinsonian symptoms","volume":"6","author":"Osawa","year":"1997","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.parkreldis.2021.05.026_bib70","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0887-8994(97)00229-4","article-title":"Parkinsonian syndrome complicating systemic lupus erythematosus","volume":"18","author":"Shahar","year":"1998","journal-title":"Pediatr. Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.05.026_bib71","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-510X(01)00604-9","article-title":"Reversible parkinsonism in systemic lupus erythematosus","volume":"193","author":"Tan","year":"2001","journal-title":"J. Neurol. Sci."},{"issue":"7","key":"10.1016\/j.parkreldis.2021.05.026_bib72","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1212\/01.wnl.0000267320.48939.d0","article-title":"CNS lupus: a study of 41 patients","volume":"69","author":"Joseph","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.parkreldis.2021.05.026_bib73","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10072-015-2443-3","article-title":"Reversible chorea and parkinsonism in a patient with systemic lupus erythematosus","volume":"37","author":"Kim","year":"2016","journal-title":"Neurol. Sci."},{"issue":"6","key":"10.1016\/j.parkreldis.2021.05.026_bib74","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/mds.10288","article-title":"Juvenile parkinsonism as a manifestation of systemic lupus erythematosus: case report and review of the literature","volume":"17","author":"Garcia-Moreno","year":"2002","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.parkreldis.2021.05.026_bib75","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.neurol.2012.03.010","article-title":"Parkinsonism as first manifestation of lupus","volume":"168","author":"Lachhab","year":"2012","journal-title":"Rev. Neurol. (Paris)"},{"issue":"3","key":"10.1016\/j.parkreldis.2021.05.026_bib76","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1468-1331.1998.530309.x","article-title":"Systemic lupus erythematosus presenting with steroid-responsive parkinsonism and post-hemiplegic dystonia","volume":"5","author":"Lim","year":"1998","journal-title":"Eur. J. Neurol."},{"issue":"12","key":"10.1016\/j.parkreldis.2021.05.026_bib77","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s10072-014-1844-z","article-title":"Acute parkinsonism as first manifestation of systemic lupus erythematosus unmasked by CMV infection","volume":"35","author":"Marino","year":"2014","journal-title":"Neurol. Sci."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.05.026_bib78","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.parkreldis.2007.08.001","article-title":"Stroke of the substance nigra and parkinsonism as first manifestation of systemic lupus erythematosus","volume":"14","author":"Orta Daniel","year":"2008","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2021.05.026_bib79","first-page":"367185","article-title":"Diffuse leukoencephalopathy and subacute parkinsonism as an early manifestation of systemic lupus erythematosus","author":"Tse","year":"2013","journal-title":"Case Rep Neurol Med"},{"issue":"4","key":"10.1016\/j.parkreldis.2021.05.026_bib80","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/mdc3.12943","article-title":"Reversible acute parkinsonism and unusual neuroimaging findings in systemic lupus erythematosus","volume":"7","author":"Moraes de Moraes","year":"2020","journal-title":"Mov Disord Clin Pract"},{"issue":"1\u20132","key":"10.1016\/j.parkreldis.2021.05.026_bib81","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jns.2007.10.003","article-title":"Parkinsonism in a patient with antiphospholipid syndrome--case report and literature review","volume":"267","author":"Huang","year":"2008","journal-title":"J. Neurol. Sci."},{"issue":"8","key":"10.1016\/j.parkreldis.2021.05.026_bib82","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1212\/WNL.0000000000000152","article-title":"Corticobasal syndrome associated with antiphospholipid syndrome without cerebral infarction","volume":"82","author":"Lee","year":"2014","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.parkreldis.2021.05.026_bib83","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/mds.20842","article-title":"Atypical movement disorders in antiphospholipid syndrome","volume":"21","author":"Martino","year":"2006","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.05.026_bib84","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1353-8020(00)00025-0","article-title":"Antiphospholipid syndrome and dystonia-parkinsonism. A case report","volume":"7","author":"Milanov","year":"2001","journal-title":"Park. Relat. Disord."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.05.026_bib85","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/1531-8257(199905)14:3<530::AID-MDS1030>3.0.CO;2-8","article-title":"Primary antiphospholipid syndrome presenting as a corticobasal degeneration syndrome","volume":"14","author":"Morris","year":"1999","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.05.026_bib86","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1191\/0961203303lu242CR","article-title":"Primary antiphospholipid antibody syndrome masquerading as progressive supranuclear palsy","volume":"12","author":"Reitblat","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.parkreldis.2021.05.026_bib87","first-page":"5872638","article-title":"Corticobasal syndrome associated with antiphospholipid syndrome secondary to systemic lupus erythematosus","author":"Hashimoto","year":"2018","journal-title":"Case Rep Neurol Med"},{"issue":"10","key":"10.1016\/j.parkreldis.2021.05.026_bib88","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.mayocp.2016.06.023","article-title":"Reduced risk of Parkinson disease in patients with rheumatoid arthritis: a nationwide population-based study","volume":"91","author":"Sung","year":"2016","journal-title":"Mayo Clin. Proc."},{"issue":"7","key":"10.1016\/j.parkreldis.2021.05.026_bib89","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s10072-014-1699-3","article-title":"Parkinsonism as an initial manifestation of rheumatoid meningitis","volume":"35","author":"Hayashi","year":"2014","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2021.05.026_bib90","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fneur.2019.00163","article-title":"Rheumatoid meningitis presenting with acute parkinsonism and protracted non-convulsive seizures: an unusual case presentation and review of treatment strategies","volume":"10","author":"Pellerin","year":"2019","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.05.026_bib91","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3988\/jcn.2020.16.2.336","article-title":"Seropositive rheumatoid arthritis presenting with reversible parkinsonism and dysphagia","volume":"16","author":"Im","year":"2020","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.parkreldis.2021.05.026_bib92","first-page":"572931","article-title":"A case of REM sleep behavior disorder, narcolepsy-cataplexy, parkinsonism, and rheumatoid arthritis","author":"Cosentino","year":"2014","journal-title":"Behav. Neurol."},{"issue":"7","key":"10.1016\/j.parkreldis.2021.05.026_bib93","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/jamaneurol.2017.0469","article-title":"Kingdom brain expression consortium, genome-wide pleiotropy between Parkinson Disease and autoimmune diseases","volume":"74","author":"Witoelar","year":"2017","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.parkreldis.2021.05.026_bib94","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1017\/S0317167100033552","article-title":"Parkinsonian syndrome as a neurological manifestation of Behcet's disease","volume":"25","author":"Bogdanova","year":"1998","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2021.05.026_bib95","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.07.2008.0569","article-title":"Sarcoidosis with basal ganglial infiltration presenting as Parkinsonism","volume":"2009","author":"Papapetropoulos","year":"2009","journal-title":"BMJ Case Rep."},{"issue":"5","key":"10.1016\/j.parkreldis.2021.05.026_bib96","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/mds.22456","article-title":"Paroxysmal dystonia associated to primary Sjogren's syndrome","volume":"24","author":"Alonso-Navarro","year":"2009","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.parkreldis.2021.05.026_bib97","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8257(199909)14:5<860::AID-MDS1024>3.0.CO;2-8","article-title":"Painful tonic\/dystonic spasms in Sjogren's syndrome","volume":"14","author":"Jabbari","year":"1999","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.parkreldis.2021.05.026_bib98","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1601-5215.2010.00485.x","article-title":"Bilateral blepharospasm as the presenting symptom of Sj\u00f6gren's syndrome with evidence of central nervous system involvement","volume":"22","author":"Kargiotis","year":"2010","journal-title":"Acta Neuropsychiatr."},{"issue":"5","key":"10.1016\/j.parkreldis.2021.05.026_bib99","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10072-014-1907-1","article-title":"Efficacy of high dose methylprednisolone in a patient with cervical dystonia and blepharospasm and Sjogren's syndrome","volume":"36","author":"Mantero","year":"2015","journal-title":"Neurol. Sci."},{"issue":"10","key":"10.1016\/j.parkreldis.2021.05.026_bib100","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s10067-006-0519-4","article-title":"Orofacial dystonia related to Sjogren's syndrome","volume":"26","author":"Papageorgiou","year":"2007","journal-title":"Clin. Rheumatol."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.05.026_bib101","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/1531-8257(199903)14:2<374::AID-MDS1032>3.0.CO;2-W","article-title":"Dystonia; a central nervous system presentation of Sjogren's syndrome","volume":"14","author":"van den Berg","year":"1999","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.05.026_bib102","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/1941874417698323","article-title":"Jaw dystonia and reversible basal ganglia changes as an initial presentation of systemic lupus erythematosus","volume":"8","author":"Romba","year":"2018","journal-title":"Neurohospitalist"},{"issue":"6","key":"10.1016\/j.parkreldis.2021.05.026_bib103","first-page":"928","article-title":"Bilateral reversible basal ganglia changes associated with dystonia and hemifacial spasms in central nervous system lupus","volume":"5","author":"Wu","year":"2015","journal-title":"Quant. Imag. Med. Surg."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.05.026_bib104","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/mds.870080327","article-title":"Hemidystonia symptomatic of primary antiphospholipid syndrome in childhood","volume":"8","author":"Angelini","year":"1993","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.05.026_bib105","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/1531-8257(200007)15:4<732::AID-MDS1021>3.0.CO;2-J","article-title":"Progressive myoclonic ataxia associated with celiac disease presenting as unilateral cortical tremor and dystonia","volume":"15","author":"Fung","year":"2000","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.parkreldis.2021.05.026_bib106","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bpa.12084","article-title":"Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature","volume":"23","author":"Jarius","year":"2013","journal-title":"Brain Pathol."},{"key":"10.1016\/j.parkreldis.2021.05.026_bib107","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/B978-0-444-64189-2.00021-4","article-title":"Immune-mediated ataxias","volume":"155","author":"Joubert","year":"2018","journal-title":"Handb. Clin. Neurol."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.05.026_bib108","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11940-019-0552-7","article-title":"Treatment of neurological manifestations of gluten sensitivity and coeliac disease","volume":"21","author":"Zis","year":"2019","journal-title":"Curr. Treat. Options Neurol."},{"issue":"6","key":"10.1016\/j.parkreldis.2021.05.026_bib109","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/s00415-010-5454-2","article-title":"Neurological manifestations of Behcet's disease in Japan: a study of 54 patients","volume":"257","author":"Ideguchi","year":"2010","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.05.026_bib110","doi-asserted-by":"crossref","DOI":"10.3390\/nu11020380","article-title":"Neurological manifestations of neuropathy and ataxia in celiac disease: a systematic review","volume":"11","author":"Mearns","year":"2019","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.parkreldis.2021.05.026_bib111","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/jnnp-2016-314863","article-title":"Causes of progressive cerebellar ataxia: prospective evaluation of 1500 patients","volume":"88","author":"Hadjivassiliou","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2021.05.026_bib112","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40673-017-0079-1","article-title":"Cerebellar ataxia with sensory ganglionopathy; does autoimmunity have a role to play?","volume":"4","author":"Zis","year":"2017","journal-title":"Cerebellum Ataxias"},{"issue":"Pt 5","key":"10.1016\/j.parkreldis.2021.05.026_bib113","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/brain\/118.5.1087","article-title":"Progressive myoclonic ataxia associated with coeliac disease. The myoclonus is of cortical origin, but the pathology is in the cerebellum","volume":"118","author":"Bhatia","year":"1995","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.parkreldis.2021.05.026_bib114","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ana.21450","article-title":"Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase","volume":"64","author":"Hadjivassiliou","year":"2008","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.05.026_bib115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-4800(03)80004-7","article-title":"Neuro-Behcet's disease: a masquerader of multiple sclerosis. A prospective study of neurologic manifestations of Behcet's disease in 96 Iranian patients","volume":"74","author":"Ashjazadeh","year":"2003","journal-title":"Exp. Mol. Pathol."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.05.026_bib116","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/mds.21834","article-title":"Ataxia and cerebellar atrophy--a novel manifestation of neuro-Behcet disease?","volume":"23","author":"Gardner","year":"2008","journal-title":"Mov. Disord."},{"issue":"11\u201312","key":"10.1016\/j.parkreldis.2021.05.026_bib117","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00508-013-0364-9","article-title":"Cortical and cerebellar atrophy, but no lesion in a patient with neuro-Behcet's disease","volume":"125","author":"Varoglu","year":"2013","journal-title":"Wien Klin. Wochenschr."},{"issue":"7","key":"10.1016\/j.parkreldis.2021.05.026_bib118","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1111\/j.1468-1331.2007.01822.x","article-title":"A case of neuro-vasculo-Behcet disease","volume":"14","author":"Gan","year":"2007","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.05.026_bib119","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s10072-006-0568-2","article-title":"An unusual case of neuro-Behcet's disease presenting with reversible basilar artery occlusion","volume":"27","author":"Lee","year":"2006","journal-title":"Neurol. Sci."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.05.026_bib120","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1212\/01.wnl.0000179219.97769.6a","article-title":"Large thalamic mass due to neuro-Behcet disease","volume":"65","author":"Schmolck","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.parkreldis.2021.05.026_bib121","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s13256-016-1151-9","article-title":"Neuro-Behcet disease presenting as a solitary cerebellar hemorrhagic lesion: a case report and review of the literature","volume":"10","author":"Yeo","year":"2016","journal-title":"J. Med. Case Rep."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.05.026_bib122","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejrad.2012.04.040","article-title":"Brain stem and cerebellar atrophy in chronic progressive neuro-Behcet's disease","volume":"82","author":"Kanoto","year":"2013","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.parkreldis.2021.05.026_bib123","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-008270","article-title":"Juvenile systemic lupus erythematosus with primary neuropsychiatric presentation","author":"Ferraria","year":"2013","journal-title":"BMJ Case Rep."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.05.026_bib124","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0303-8467(99)00078-5","article-title":"Acute cerebellar ataxia of a patient with SLE","volume":"102","author":"Yaginuma","year":"2000","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"8","key":"10.1016\/j.parkreldis.2021.05.026_bib125","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1177\/0961203309356457","article-title":"Fifteen-year-old girl with systemic lupus erythematosus and unilateral cerebellitis","volume":"19","author":"Krief","year":"2010","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.parkreldis.2021.05.026_bib126","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/ard.53.5.327","article-title":"Cerebellum and brainstem vasculopathy in systemic lupus erythematosus: two clinico-pathological cases","volume":"53","author":"Smith","year":"1994","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.parkreldis.2021.05.026_bib127","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2169\/internalmedicine.53.0514","article-title":"Successful use of intensive immunosuppressive therapy for treating simultaneously occurring cerebral lesions and pulmonary arterial hypertension in a patient with systemic lupus erythematosus","volume":"53","author":"Watanabe","year":"2014","journal-title":"Intern. Med."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.05.026_bib128","doi-asserted-by":"crossref","first-page":"299","DOI":"10.7196\/SAMJ.2017.v107i4.12053","article-title":"Systemic lupus erythematosus: a possible cause of non-alcoholic Wernicke's encephalopathy","volume":"107","author":"Nyo","year":"2017","journal-title":"S. Afr. Med. J."},{"issue":"11","key":"10.1016\/j.parkreldis.2021.05.026_bib129","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1007\/s00296-017-3773-7","article-title":"Cerebellar ataxia and obstructive hydrocephalus, rare neurologic presentations in patients with systemic lupus erythematosus","volume":"37","author":"Ahmed","year":"2017","journal-title":"Rheumatol. Int."},{"issue":"5","key":"10.1016\/j.parkreldis.2021.05.026_bib130","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/096120339500400513","article-title":"Cerebellar atrophy in systemic lupus erythematosus","volume":"4","author":"al-Arfaj","year":"1995","journal-title":"Lupus"},{"key":"10.1016\/j.parkreldis.2021.05.026_bib131","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-214549","article-title":"Diminution of falsely elevated tumour markers following immunosuppression for systemic lupus erythematosus with neurological involvement","author":"Bevan","year":"2016","journal-title":"BMJ Case Rep."},{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2021.05.026_bib132","first-page":"S75","article-title":"Cerebellar ataxia in a young patient: a rare path to lupus","volume":"5","author":"Ghosh","year":"2014","journal-title":"J. Neurosci. Rural Pract."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.05.026_bib133","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1177\/0961203311418270","article-title":"Subacute cerebellar ataxia and atrophy developed in a young woman with systemic lupus erythematosus whose cerebrospinal fluid was positive for antineuronal cell antibody","volume":"21","author":"Iwasaki","year":"2012","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.parkreldis.2021.05.026_bib134","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0303-8467(96)00013-3","article-title":"Subacute pancerebellar syndrome associated with systemic lupus erythematosus","volume":"98","author":"Manto","year":"1996","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"8867","key":"10.1016\/j.parkreldis.2021.05.026_bib135","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0140-6736(93)91524-P","article-title":"Purkinje cell antibody in lupus ataxia","volume":"342","author":"Shimomura","year":"1993","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.parkreldis.2021.05.026_bib136","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1177\/0961203308093071","article-title":"Cerebellar ataxia in systemic lupus erythematosus","volume":"17","author":"Appenzeller","year":"2008","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.parkreldis.2021.05.026_bib137","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0303-8467(99)00009-8","article-title":"Vertebrobasilar artery territory infarction as an initial manifestation of systemic lupus erythematosus","volume":"101","author":"Kwon","year":"1999","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.05.026_bib138","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1600-0404.1992.tb05111.x","article-title":"Magnetic resonance imaging findings in lupus ataxia","volume":"86","author":"Lancman","year":"1992","journal-title":"Acta Neurol. Scand."},{"issue":"12","key":"10.1016\/j.parkreldis.2021.05.026_bib139","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1177\/0961203311403346","article-title":"Acute cerebellar ataxia in lupus","volume":"20","author":"Chattopadhyay","year":"2011","journal-title":"Lupus"},{"issue":"19","key":"10.1016\/j.parkreldis.2021.05.026_bib140","article-title":"Sjogren sensory neuronopathy (sjogren ganglionopathy): long-term outcome and treatment response in a series of 13 cases","volume":"95","author":"Pereira","year":"2016","journal-title":"Medicine (Baltim.)"},{"issue":"2","key":"10.1016\/j.parkreldis.2021.05.026_bib141","first-page":"81","article-title":"Sjogren's syndrome with acute cerebellar ataxia and massive lymphadenopathy : a case report","volume":"22","author":"Chen","year":"2013","journal-title":"Acta Neurol. Taiwan"},{"issue":"11","key":"10.1016\/j.parkreldis.2021.05.026_bib142","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s00415-007-0596-6","article-title":"Asymmetric cerebellar ataxia and limbic encephalitis as a presenting feature of primary Sjogren's syndrome","volume":"254","author":"Collison","year":"2007","journal-title":"J. Neurol."},{"key":"10.1016\/j.parkreldis.2021.05.026_bib143","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40673-016-0056-0","article-title":"Progressive cerebellar degeneration revealing Primary Sjogren Syndrome: a case report","volume":"3","author":"Farhat","year":"2016","journal-title":"Cerebellum Ataxias"},{"issue":"9","key":"10.1016\/j.parkreldis.2021.05.026_bib144","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/088307380101600911","article-title":"Central nervous system Sjogren's syndrome in a child: case report and review of the literature","volume":"16","author":"Gottfried","year":"2001","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.parkreldis.2021.05.026_bib145","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-223952","article-title":"Cerebellar degeneration in primary Sjgren syndrome","author":"Heidary","year":"2018","journal-title":"BMJ Case Rep."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.05.026_bib146","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3988\/jcn.2012.8.2.155","article-title":"Cerebellar degeneration associated with Sjogren's syndrome","volume":"8","author":"Kim","year":"2012","journal-title":"J. Clin. Neurol."},{"issue":"12","key":"10.1016\/j.parkreldis.2021.05.026_bib147","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00296-008-0615-7","article-title":"Cerebellar ataxia in a patient with primary Sjogren's syndrome after treatment with chloroquine","volume":"28","author":"Milic","year":"2008","journal-title":"Rheumatol. Int."},{"issue":"1\u20132","key":"10.1016\/j.parkreldis.2021.05.026_bib148","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-510X(02)00034-5","article-title":"Motor weakness and cerebellar ataxia in Sjogren syndrome--identification of antineuronal antibody: a case report","volume":"197","author":"Owada","year":"2002","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.05.026_bib149","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jocn.2013.04.019","article-title":"Primary Sjogren's syndrome presenting as acute cerebellitis","volume":"21","author":"Sharma","year":"2014","journal-title":"J. Clin. Neurosci."},{"issue":"8900","key":"10.1016\/j.parkreldis.2021.05.026_bib150","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0140-6736(94)91864-3","article-title":"Antineuronal antibody in Sjogren's syndrome masquerading as paraneoplastic cerebellar degeneration","volume":"343","author":"Terao","year":"1994","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.parkreldis.2021.05.026_bib151","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1212\/01.WNL.0000130347.69790.E8","article-title":"Acute cerebellar ataxia due to Sjogren syndrome","volume":"62","author":"Wong","year":"2004","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.parkreldis.2021.05.026_bib152","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s10067-018-4000-y","article-title":"Cerebellar involvement in patients withprimary Sjogren's syndrome: diagnosis and treatment","volume":"37","author":"Yang","year":"2018","journal-title":"Clin. Rheumatol."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.05.026_bib153","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/jnnp-2019-322373","article-title":"Characterisation of ataxia in Sjogren's syndrome","volume":"91","author":"Jaques","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.parkreldis.2021.05.026_bib154","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.parkreldis.2010.11.016","article-title":"Dementia, ataxia and parkinsonism associated with the antiphospholipid syndrome","volume":"17","author":"Friedman","year":"2011","journal-title":"Park. Relat. Disord."},{"issue":"7","key":"10.1016\/j.parkreldis.2021.05.026_bib155","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.braindev.2009.07.009","article-title":"Recurrent acute cerebellar ataxia associated with anti-cardiolipin antibodies","volume":"32","author":"Ishikawa","year":"2010","journal-title":"Brain Dev."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.05.026_bib156","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-234303","article-title":"HHV-6: an unusual cause of cerebellar ataxia","volume":"13","author":"Abu Sitta","year":"2020","journal-title":"BMJ Case Rep."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.05.026_bib157","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s12311-013-0528-1","article-title":"Leukoencephalopathy due to oral methotrexate","volume":"13","author":"Gonzalez-Suarez","year":"2014","journal-title":"Cerebellum"},{"issue":"6","key":"10.1016\/j.parkreldis.2021.05.026_bib158","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.seizure.2012.04.003","article-title":"Refractory coeliac disease associated with late onset epilepsy, ataxia, tremor and progressive myoclonus with giant cortical evoked potentials--a case report and review of literature","volume":"21","author":"Javed","year":"2012","journal-title":"Seizure"},{"issue":"4","key":"10.1016\/j.parkreldis.2021.05.026_bib159","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/mdc3.12753","article-title":"Stimulus sensitive foot myoclonus: a clue to coeliac disease","volume":"6","author":"Jesus","year":"2019","journal-title":"Mov Disord Clin Pract"},{"issue":"11","key":"10.1016\/j.parkreldis.2021.05.026_bib160","first-page":"OD07-8","article-title":"Gluten sensitivity - a potentially reversible cause of progressive cerebellar ataxia and myoclonus","volume":"9","author":"Khwaja","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"issue":"14","key":"10.1016\/j.parkreldis.2021.05.026_bib161","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1002\/mds.22576","article-title":"Gluten sensitivity presenting as myoclonic epilepsy with cerebellar syndrome","volume":"24","author":"Sallem","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.05.026_bib162","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/2053-8871-1-11","article-title":"Myoclonus ataxia and refractory coeliac disease","volume":"1","author":"Sarrigiannis","year":"2014","journal-title":"Cerebellum Ataxias"},{"issue":"6","key":"10.1016\/j.parkreldis.2021.05.026_bib163","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1212\/WNL.54.6.1350","article-title":"Cortical myoclonus and cerebellar pathology","volume":"54","author":"Tijssen","year":"2000","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.parkreldis.2021.05.026_bib164","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1212\/WNL.49.4.1131","article-title":"CSF antigliadin antibodies and the Ramsay Hunt syndrome","volume":"49","author":"Chinnery","year":"1997","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.parkreldis.2021.05.026_bib165","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1212\/WNL.0000000000000077","article-title":"Progressive myoclonic epilepsies: definitive and still undetermined causes","volume":"82","author":"Franceschetti","year":"2014","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.parkreldis.2021.05.026_bib166","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.pediatrneurol.2005.08.034","article-title":"Opsoclonus-myoclonus associated with celiac disease","volume":"34","author":"Deconinck","year":"2006","journal-title":"Pediatr. Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.05.026_bib167","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mds.20262","article-title":"Paroxysmal non-kinesigenic dyskinesia in antiphospholipid syndrome","volume":"20","author":"Engelen","year":"2005","journal-title":"Mov. Disord."},{"issue":"23","key":"10.1016\/j.parkreldis.2021.05.026_bib168","doi-asserted-by":"crossref","first-page":"e2727","DOI":"10.1212\/WNL.0000000000007619","article-title":"Pearls & Oy-sters: paroxysmal dysarthria-ataxia syndrome: acoustic analysis in a case of antiphospholipid syndrome","volume":"92","author":"Gessani","year":"2019","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.parkreldis.2021.05.026_bib169","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/mds.21148","article-title":"Paroxysmal nonkinesigenic dystonia and celiac disease","volume":"22","author":"Hall","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.05.026_bib170","doi-asserted-by":"crossref","first-page":"105586","DOI":"10.1016\/j.clineuro.2019.105586","article-title":"Paroxismal non-kinesigenic dyskinesia and hemidystonia associated with silent celiac disease","volume":"188","author":"Bago Rozankovic","year":"2020","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.parkreldis.2021.05.026_bib171","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tvjl.2016.12.017","article-title":"Classification of involuntary movements in dogs: paroxysmal dyskinesias","volume":"220","author":"Lowrie","year":"2017","journal-title":"Vet. J."},{"issue":"5","key":"10.1016\/j.parkreldis.2021.05.026_bib172","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/BF00878879","article-title":"Paroxysmal dysarthria and ataxia in a patient with Behcet's disease","volume":"242","author":"Akman-Demir","year":"1995","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.05.026_bib173","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/1531-8257(199901)14:1<177::AID-MDS1037>3.0.CO;2-N","article-title":"Paroxysmal dystonia in Behcet's disease","volume":"14","author":"Pellecchia","year":"1999","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.05.026_bib174","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000047979","article-title":"Paroxysmal focal dystonia in neuro-Behcet by a small ipsilateral thalamic lesion","volume":"47","author":"Guak","year":"2002","journal-title":"Eur. Neurol."},{"issue":"22","key":"10.1016\/j.parkreldis.2021.05.026_bib175","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.3748\/wjg.v23.i22.4132","article-title":"Is tremor related to celiac disease?","volume":"23","author":"Ameghino","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.05.026_bib176","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/WNO.0000000000000159","article-title":"Neuro-Behcet disease presenting with oculopalatal tremor","volume":"35","author":"Morgan","year":"2015","journal-title":"J. Neuro Ophthalmol."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.05.026_bib177","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/mds.23987","article-title":"Progressive ataxia with palatal tremor due to gluten sensitivity","volume":"27","author":"Kheder","year":"2012","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.05.026_bib178","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/0028-3886.24713","article-title":"Neuropsychiatric manifestations systemic lupus erythematosus: a study from South India","volume":"54","author":"Robert","year":"2006","journal-title":"Neurol. India"},{"issue":"16","key":"10.1016\/j.parkreldis.2021.05.026_bib179","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1002\/mds.22821","article-title":"Neurological symptoms in patients with biopsy proven celiac disease","volume":"24","author":"Burk","year":"2009","journal-title":"Mov. Disord."},{"issue":"8697","key":"10.1016\/j.parkreldis.2021.05.026_bib180","first-page":"1078","article-title":"Criteria for diagnosis of behcet's disease. International study group for behcet's disease","volume":"335","year":"1990","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.parkreldis.2021.05.026_bib181","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.05.026_bib182","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/jdv.12107","article-title":"International Team for the Revision of the International Criteria for Behcet's, D., the International Criteria for Behcet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria","volume":"28","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"10115","key":"10.1016\/j.parkreldis.2021.05.026_bib183","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0140-6736(17)31796-8","article-title":"Coeliac disease","volume":"391","author":"Lebwohl","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.parkreldis.2021.05.026_bib184","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemostasis"},{"issue":"8","key":"10.1016\/j.parkreldis.2021.05.026_bib185","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.05.026_bib186","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American College of rheumatology\/European league against rheumatism classification Criteria for primary sjogren's syndrome: a Consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheum."},{"issue":"20","key":"10.1016\/j.parkreldis.2021.05.026_bib187","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/WNL.0000000000000970","article-title":"The neurologic significance of celiac disease biomarkers","volume":"83","author":"McKeon","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2021.05.026_bib188","doi-asserted-by":"crossref","first-page":"239398","DOI":"10.1155\/2014\/239398","article-title":"Revisiting the molecular mechanism of neurological manifestations in antiphospholipid syndrome: beyond vascular damage","volume":"2014","author":"Carecchio","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.parkreldis.2021.05.026_bib189","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fneur.2012.00150","article-title":"Antiphospholipid-related chorea","volume":"3","author":"Peluso","year":"2012","journal-title":"Front. Neurol."},{"issue":"7660","key":"10.1016\/j.parkreldis.2021.05.026_bib190","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature22815","article-title":"T cells from patients with Parkinson's disease recognize alpha-synuclein peptides","volume":"546","author":"Sulzer","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.parkreldis.2021.05.026_bib191","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3389\/fimmu.2019.00303","article-title":"Autoimmunity in Parkinson's disease: the role of alpha-synuclein-specific T cells","volume":"10","author":"Garretti","year":"2019","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.parkreldis.2021.05.026_bib192","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41583-019-0233-2","article-title":"B cells in autoimmune and neurodegenerative central nervous system diseases","volume":"20","author":"Sabatino","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.05.026_bib193","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3109\/03009742.2011.633099","article-title":"Increased serum levels of high-mobility group box 1 (HMGB1) in primary Sjogren's syndrome","volume":"41","author":"Dupire","year":"2012","journal-title":"Scand. J. Rheumatol."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.05.026_bib194","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.expneurol.2015.11.003","article-title":"Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson's disease","volume":"275","author":"Sasaki","year":"2016","journal-title":"Exp. Neurol."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.05.026_bib195","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.948","article-title":"High expression of the HMGB1-TLR4 axis and its downstream signaling factors in patients with Parkinson's disease and the relationship of pathological staging","volume":"8","author":"Yang","year":"2018","journal-title":"Brain Behav"},{"key":"10.1016\/j.parkreldis.2021.05.026_bib196","doi-asserted-by":"crossref","DOI":"10.1139\/cjpp-2019-0337","article-title":"Suppression of high-mobility group box 1 ameliorates xerostomia in a sjogren syndrome-triggered mouse model","author":"Wang","year":"2020","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.05.026_bib197","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/cei.12160","article-title":"Aicardi-Goutieres syndrome: a model disease for systemic autoimmunity","volume":"175","author":"Lee-Kirsch","year":"2014","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.parkreldis.2021.05.026_bib198","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1152\/jn.1997.77.5.2842","article-title":"Animal model explains the origins of the cranial dystonia benign essential blepharospasm","volume":"77","author":"Schicatano","year":"1997","journal-title":"J. Neurophysiol."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.05.026_bib199","first-page":"53","article-title":"Animal models for investigating benign essential blepharospasm","volume":"11","author":"Evinger","year":"2013","journal-title":"Curr. Neuropharmacol."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021001978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021001978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:23:24Z","timestamp":1761179004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802021001978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":199,"alternative-id":["S1353802021001978"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.05.026","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Movement disorders in systemic autoimmune diseases: Clinical spectrum, ancillary investigations, pathophysiological considerations","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.05.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}